Utah Retirement Systems’s Apellis Pharmaceuticals APLS Stock Holding History

Utah Retirement Systems’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,600	Closed	-$225K	–	1029
2026 Q1	$225K	Buy	+5,600	New	+$121K	﹤0.01%	931
2024 Q3	–	Sell	-5,600	Closed	-$215K	–	989
2024 Q2	$215K	Hold	5,600	–	–	﹤0.01%	939
2024 Q1	$329K	Hold	5,600	–	–	﹤0.01%	841
2023 Q4	$335K	Buy	5,600 +200	+4%	+$10.1K	﹤0.01%	852
2023 Q3	$205K	Hold	5,400	–	–	﹤0.01%	938
2023 Q2	$492K	Buy	+5,400	New	+$466K	0.01%	820

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Utah Retirement Systems's APLS Position: Q2 2026 in Review

Utah Retirement Systems sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 5,600 shares — an estimated $225K sold.

Utah Retirement Systems first reported a position in APLS in Q2 2023 and held it in 6 quarters. The position peaked at $492K in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Utah Retirement Systems reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Utah Retirement Systems sold 5,600 Apellis Pharmaceuticals shares in Q2 2026, an estimated $225K.
Utah Retirement Systems first reported a position in Apellis Pharmaceuticals in Q2 2023 and held it in 6 quarters.
Utah Retirement Systems's Apellis Pharmaceuticals position peaked at $492K in Q2 2023.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Utah Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.